This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Acquired absence of limb
Z21_ACQUI_ABSENCE_LIMB
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
326 |
4. Check minimum number of eventsNone |
326 |
5. Include endpointsNone |
326 |
6. Filter based on genotype QC (FinnGen only) |
326 |
Control definitions (FinnGen only)
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z[8-9]
Similar endpoints
↥List of similar endpoints to
Acquired absence of limb
based on the number of shared cases.
Similar with more cases:
- Persons with potential health hazards related to family and personal history and certain conditions influencing health status
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 326 | 100 | 226 |
| Unadjusted period prevalence (%) | 0.08 | 0.03 | 0.10 |
| Median age at first event (years) | 65.29 | 59.80 | 67.71 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 295
- Matched controls
- 2948
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z89.5
ICD-10 Finland
Acquired absence of leg at or below knee
+∞
160.5
139
*
NGQ20
NOMESCO Finland
Amputation of lower leg
2179.0
141.8
126
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
24.0
108.7
172
162
NHQ40
NOMESCO Finland
Amputation of toe
89.5
93.3
101
17
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
51.6
91.2
109
33
Z89.6
ICD-10 Finland
Acquired absence of leg above knee
+∞
90.4
82
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
26.2
80.5
116
71
NFQ20
NOMESCO Finland
Amputation of femur
178.8
78.4
79
6
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
85.2
74.1
81
13
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
38.2
72.8
93
35
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
24.5
71.1
104
64
SPAT1148
SPAT
Treatment of chronic ulcer or burn
12.4
69.5
145
213
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
169.2
64.9
66
5
J01FF01
ATC
clindamycin; systemic
9.0
64.1
183
453
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
65.1
61.4
70
14
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
714.9
61.0
58
*
S97
ICPC
Chronic ulcer skin
19.8
59.2
93
67
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
13.9
52.9
97
100
A10AE04
ATC
insulin glargine; parenteral
12.5
51.9
101
118
ZZA00
NOMESCO Finland
Split skin graft
28.7
45.5
62
27
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
62.7
45.4
52
10
N02AA05
ATC
oxycodone; systemic
7.7
45.1
124
255
A46
ICD-10 Finland
Erysipelas
7.8
44.2
119
236
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
13.1
43.6
81
83
SPAT1229
SPAT
Assessment of need for aid
11.2
42.9
87
106
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
11.1
42.7
87
107
C03CA01
ATC
furosemide; systemic
5.7
41.5
169
565
ZXD05
NOMESCO Finland
Urgent procedure
5.7
41.4
168
558
L28
ICPC
Limited function/disability (L)
7.4
41.0
113
228
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
6.8
40.2
121
275
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
100.4
40.0
43
5
TQW11
NOMESCO Finland
Vacuum treatment of wound
29.7
38.7
52
21
Z89.4
ICD-10 Finland
Acquired absence of foot and ankle
+∞
38.4
36
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
6.4
38.1
120
286
A10AA02
ATC
NA
19.4
37.0
57
36
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
67.7
36.2
41
7
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
50.1
36.1
43
10
WX213
NOMESCO Finland
Lower leg blockade
108.7
35.7
38
*
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
10.1
35.5
75
96
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
8.0
35.0
87
146
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
29.2
34.9
47
19
103
Kela drug reimbursment
Diabetes, insulin-treated
4.9
34.9
155
539
N03AX16
ATC
pregabalin; oral
5.4
34.7
132
387
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
18.6
34.6
54
35
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
374.1
33.6
33
*
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
22.3
33.6
49
26
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
31.2
32.6
43
16
Z96.1
ICD-10 Finland
Presence of intraocular lens
28.5
32.5
44
18
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
99.0
32.5
35
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.9
31.9
103
244
J01MA12
ATC
levofloxacin; systemic
5.0
31.0
122
362
SPAT1149
SPAT
Suture or treatment of traumatic wound
6.2
30.3
92
200
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
119.2
30.3
32
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
115.0
29.3
31
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
23.1
29.2
42
21
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
18.7
29.1
45
28
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.4
29.1
85
175
J01MA02
ATC
ciprofloxacin; systemic
4.1
29.1
175
770
H3603, E103
ICD-10 Finland
NA
86.4
28.4
31
*
A10AA01
ATC
NA
18.3
28.3
44
28
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
9.6
28.2
60
76
SPAT1262
SPAT
Handing over of treatment supplies
4.8
27.7
110
322
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.9
27.4
182
855
NGQ48
NOMESCO Finland
Revision of exarticulation or amputation stump of knee or lower leg
296.7
27.2
27
*
L89
ICD-10 Finland
Decubitus ulcer and pressure area
19.6
27.1
41
24
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
22.3
26.9
39
20
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
9.9
26.9
56
68
A12AA04
ATC
calcium carbonate; oral
41.0
26.8
33
9
Z49.1
ICD-10 Finland
Extracorporeal dialysis
44.6
26.4
32
8
I50.9
ICD-10 Finland
Heart failure, unspecified
5.4
25.8
87
211
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
23.9
25.5
36
17
T87.4
ICD-10 Finland
Infection of amputation stump
+∞
25.4
24
*
Z89.1
ICD-10 Finland
Acquired absence of hand and wrist
+∞
25.4
24
*
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
98.8
25.1
27
*
M86.6
ICD-10 Finland
Other chronic osteomyelitis
272.1
25.1
25
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
4.5
25.0
107
332
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
13.1
24.7
44
39
S18
ICPC
Laceration/cut
3.6
24.6
172
818
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
23.2
24.5
35
17
L29
ICPC
Musculoskeletal sympt/complt other
8.4
24.0
55
78
SPAT1263
SPAT
Sampling
3.6
23.9
171
821
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
19.4
23.8
36
21
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
7.2
23.8
61
103
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
16.6
23.7
38
26
SPAT1231
SPAT
Assessment of adjustments needed in living environment
18.5
23.4
36
22
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
13.4
23.3
41
35
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
11.6
23.3
44
44
PE1BT
NOMESCO Finland
Femoral artery extensive PTA
71.0
23.2
26
*
S91.3
ICD-10 Finland
Open wound of other parts of foot
17.7
23.0
36
23
I79.2*E10.5
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
248.5
23.0
23
*
V03AE02
ATC
sevelamer; oral
130.1
22.9
24
*
I79.2*E11.5
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
130.1
22.9
24
*
PE1AT
NOMESCO Finland
Femoral artery PTA
35.5
22.9
29
9
H3603, E113
ICD-10 Finland
NA
49.3
22.8
27
6
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
11.5
22.7
43
43
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.9
22.6
118
431
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.9
22.5
118
433
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
38.5
22.5
28
8
SPAT1222
SPAT
Counselling/guidance promoting independent living
4.8
22.4
85
230
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
68.0
22.2
25
*
Z42.4
ICD-10 Finland
Follow-up care involving plastic surgery of lower extremity
+∞
22.2
21
*
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
12.3
21.9
40
37
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
34.2
21.9
28
9
SPAT1151
SPAT
Treatment of major wounds
34.2
21.9
28
9
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
13.5
21.8
38
32
L81
ICPC
Injury musculoskeletal NOS
18.4
21.5
33
20
A28
ICPC
Limited function/disability NOS
4.6
21.4
85
240
TK800
NOMESCO Finland
Hemodialysis
21.5
21.3
31
16
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
65.0
21.2
24
*
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
+∞
21.1
20
*
H43.1
ICD-10 Finland
Vitreous haemorrhage
18.7
21.0
32
19
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
15.9
20.9
34
24
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
225.2
20.9
21
*
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
4.8
20.5
75
194
NG4AA
NOMESCO Finland
Lower leg X-ray examination
14.6
20.3
34
26
N02AX02
ATC
tramadol; systemic, rectal
3.2
20.1
172
899
A10AE05
ATC
insulin detemir; parenteral
9.1
20.1
43
54
Z89.7
ICD-10 Finland
Acquired absence of both lower limbs [any level, except toes alone]
+∞
20.0
19
*
V03AE01
ATC
polystyrene sulfonate; oral
31.5
20.0
26
9
TPH04
NOMESCO Finland
Cathetrisation of vein
3.8
19.8
101
355
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
19.7
117
466
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
18.4
19.6
30
18
T89
ICPC
Diabetes insulin dependent
12.7
19.6
35
31
N18.8
ICD-10 Finland
Other chronic renal failure
11.3
19.5
37
37
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.1
19.1
55
107
SPAT1216
SPAT
Assessment of functional ability
4.1
19.1
86
271
B03XA02
ATC
darbepoetin alfa; parenteral
20.5
19.0
28
15
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
3.3
18.9
122
514
PE1YT
NOMESCO Finland
Femoral or popliteal artery PTA with stent
41.3
18.8
23
6
N03AX12
ATC
gabapentin; oral
4.4
18.8
76
216
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
32.5
18.6
24
8
QDA10
NOMESCO Finland
Incision of skin of lower limb
47.4
18.5
22
5
B01AC04
ATC
clopidogrel; oral
4.0
18.1
81
252
L14
ICPC
Leg/thigh symptom/complaint
6.5
17.9
48
85
M14.6*E11.6
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic neuropathic
+∞
17.9
17
*
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
191.0
17.7
18
*
N18.0
ICD-10 Finland
End-stage renal disease
31.0
17.7
23
8
SPAT1255
SPAT
Intravenous administration of medicine
6.3
17.6
49
91
J01DB01
ATC
cefalexin; oral
3.8
17.4
255
1848
TPX10
NOMESCO Finland
Implantation of vascular injection port
13.2
17.3
30
25
L17
ICPC
Foot/toe symptom/complaint
3.5
17.3
98
368
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
5.1
17.1
57
132
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
5.1
17.1
57
132
WX320
NOMESCO Finland
Spinalanesthesy
3.3
17.0
104
415
A10BB01
ATC
glibenclamide; oral
7.4
16.9
41
63
127
Kela drug reimbursment
Transplant complication
+∞
16.8
16
*
Z94.0
ICD-10 Finland
Kidney transplant status
+∞
16.8
16
*
NFQ48
NOMESCO Finland
Revision of exarticulation or amputation stump of hip or femur
+∞
16.8
16
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.7
16.7
34
39
QDE35
NOMESCO Finland
Repair of skin defect in lower limb after surgery or injury
42.7
16.5
20
5
A11CC03
ATC
alfacalcidol; systemic
13.9
16.5
28
22
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
6.4
16.4
44
78
WX212
NOMESCO Finland
Femoral plexus blockade
14.7
16.3
27
20
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.5
16.2
61
160
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
15.7
16.2
26
18
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
3.2
16.2
104
428
XCK10
NOMESCO Finland
Photography of fundus of eye
4.9
16.0
55
131
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
35.6
15.9
20
6
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
63.6
15.9
18
*
H25.8
ICD-10 Finland
Other senile cataract
5.2
15.8
51
113
Z49.2
ICD-10 Finland
Other dialysis
+∞
15.8
15
*
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
90.0
15.7
17
*
CKC12
NOMESCO Finland
Photocoagulation of retina
9.6
15.7
32
37
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
168.6
15.6
16
*
M86.4
ICD-10 Finland
Chronic osteomyelitis with draining sinus
168.6
15.6
16
*
A41.9
ICD-10 Finland
Sepsis, unspecified
7.2
15.5
38
59
A10BB12
ATC
glimepiride; oral
5.3
15.5
49
106
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.9
15.5
71
223
ZXA05
NOMESCO Finland
Left side
3.1
15.4
105
447
H3601, E113
ICD-10 Finland
NA
21.5
15.3
22
11
H36.01
ICD-10 Finland
Diabetic maculopathy
25.0
15.3
21
9
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
17.7
15.0
23
14
SPAT1301
SPAT
No procedures
2.9
15.0
124
597
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
26.7
14.9
20
8
TNX30
NOMESCO Finland
Soft bandage, unspecified region
22.5
14.9
21
10
QDG00
NOMESCO Finland
Debridement of bedsore of lower limb
84.4
14.7
16
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
+∞
14.7
14
*
G54.6
ICD-10 Finland
Phantom limb syndrome with pain
157.5
14.6
15
*
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
5.6
14.4
43
87
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
11.8
14.3
26
24
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
11.8
14.3
26
24
SPAT1211
SPAT
Application of soft bandage
4.5
14.3
53
136
177
Kela drug reimbursment
Insulin glargine 300 U / ml
15.5
14.3
23
16
ZPB22
NOMESCO Finland
Autograft of vein
44.9
14.3
17
*
A10BH01
ATC
sitagliptin; oral
4.8
14.2
49
117
CKC10
NOMESCO Finland
Local photocoagulation of retina
14.6
14.0
23
17
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
14.6
14.0
23
17
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
25.3
14.0
19
8
137
Kela drug reimbursment
Uraemia requiring dialysis
56.2
14.0
16
*
PH2CD
NOMESCO Finland
Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity
56.2
14.0
16
*
B05DA
ATC
Isotonic solutions
78.9
13.7
15
*
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
17.3
13.7
21
13
L04AA06
ATC
mycophenolic acid; systemic
35.9
13.7
17
5
V03AE03
ATC
lanthanum carbonate; oral
+∞
13.6
13
*
T90
ICPC
Diabetes non-insulin dependent
3.0
13.6
96
411
WX210
NOMESCO Finland
Plexus blockade of nervus ichiadicus
146.5
13.6
14
*
M14.6
ICD-10 Finland
Neuropathic arthropathy
146.5
13.6
14
*
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
146.5
13.6
14
*
M86.1
ICD-10 Finland
Other acute osteomyelitis
146.5
13.6
14
*
M14.6*A52.1
ICD-10 Finland
Charcot's or tabetic arthropathy
146.5
13.6
14
*
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
146.5
13.6
14
*
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
7.2
13.5
33
51
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
5.6
13.5
40
80
CKC15
NOMESCO Finland
Panretinal photocoagulation
27.2
13.5
18
7
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
6.4
13.5
36
63
L84
ICD-10 Finland
Corns and callosities
13.0
13.3
23
19
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
13.0
13.3
23
19
WX214
NOMESCO Finland
Plexus blockade at the ankle
42.2
13.3
16
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.8
13.2
59
180
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.6
13.2
39
78
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.5
13.0
65
218
A02BC02
ATC
pantoprazole; systemic
2.5
12.9
201
1346
JN4AD
NOMESCO Finland
Body CT examination
4.5
12.8
47
119
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.7
12.8
108
514
WX872
NOMESCO Finland
Intensive care
6.3
12.7
34
60
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
33.7
12.7
16
5
WW500
NOMESCO Finland
Blood transfusion
7.7
12.6
29
41
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
14.0
12.6
21
16
Z89.2
ICD-10 Finland
Acquired absence of upper limb above wrist
+∞
12.6
12
*
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
+∞
12.6
12
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.7
12.6
109
527
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
6.9
12.5
31
49
Z97.4
ICD-10 Finland
Presence of external hearing-aid
135.5
12.5
13
*
S88.1
ICD-10 Finland
Traumatic amputation at level between knee and ankle
135.5
12.5
13
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
12.5
109
530
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
8.4
12.4
27
35
C07AB07
ATC
bisoprolol; oral
2.4
12.2
161
974
A10BA02
ATC
metformin; oral
2.6
12.1
113
568
NF3AA
NOMESCO Finland
Femur X-ray examination
11.2
12.0
22
21
H36.00
ICD-10 Finland
Diabetic background retinopathy
15.5
12.0
19
13
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.8
11.9
92
412
WX100
NOMESCO Finland
Conjunctival surface anesthesia
4.2
11.8
46
124
CKD40
NOMESCO Finland
Endophotocoagulation of retina
31.5
11.8
15
5
NH2AA
NOMESCO Finland
Heel X-ray examination
31.5
11.8
15
5
L03.9
ICD-10 Finland
Cellulitis, unspecified
10.7
11.7
22
22
196
Kela drug reimbursment
Paricalcitol and cinacalcet
67.7
11.7
13
*
B05DB
ATC
Hypertonic solutions
67.7
11.7
13
*
PD4CC
NOMESCO Finland
Very extensive arterigography of lower extremity with X-ray
67.7
11.7
13
*
C01DA14
ATC
isosorbide mononitrate; oral
3.2
11.7
69
260
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.1
11.6
71
273
AA1AD
NOMESCO Finland
CT of head and brain
2.7
11.6
91
413
Z44.1
ICD-10 Finland
Fitting and adjustment of artificial leg (complete)(partial)
+∞
11.5
11
*
M86.8
ICD-10 Finland
Other osteomyelitis
+∞
11.5
11
*
S91.1
ICD-10 Finland
Open wound of toe(s) without damage to nail
12.5
11.5
20
17
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.4
11.5
43
111
M14.6*E10.6
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic neuropathic
124.7
11.5
12
*
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
124.7
11.5
12
*
C09AA02
ATC
enalapril; systemic
2.8
11.5
88
392
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
11.2
11.5
21
20
B01AA03
ATC
warfarin; systemic
2.7
11.3
88
396
X58
ICD-10 Finland
Exposure to other specified factors
3.4
11.3
59
203
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
13.4
11.3
19
15
J01MA14
ATC
moxifloxacin; systemic
4.0
11.1
46
131
ZXA00
NOMESCO Finland
Right side
2.6
11.1
97
466
QDB99
NOMESCO Finland
Other procedure for wound of skin of lower limb
45.1
11.0
13
*
H3601, E103
ICD-10 Finland
NA
45.1
11.0
13
*
PEH57
NOMESCO Finland
Bypass from femoral artery to popliteal artery below knee
16.3
11.0
17
11
Z49.0
ICD-10 Finland
Preparatory care for dialysis
29.3
10.8
14
5
QXB10
NOMESCO Finland
Exchange of dressing for large skin wound, unspecified location
29.3
10.8
14
5
J04AB02
ATC
rifampicin; systemic
13.6
10.8
18
14
PD4AD
NOMESCO Finland
CT of lower extremity arteries
62.3
10.7
12
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.5
10.7
51
164
C09AA05
ATC
ramipril; oral
2.6
10.6
93
446
ZXE20
NOMESCO Finland
More than three and less than five hours
3.2
10.6
59
213
S20
ICPC
Corn/callosity
12.7
10.5
18
15
NHS99
NOMESCO Finland
Other operation for infection of tendon, joint or bone of ankle or foot
113.9
10.5
11
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
10.5
10
*
T87.6
ICD-10 Finland
Other and unspecified complications of amputation stump
+∞
10.5
10
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.3
10.5
57
201
PD4BD
NOMESCO Finland
Extensive CT of lower extremity arteries
33.9
10.4
13
*
TPX15
NOMESCO Finland
Removal of vascular injection port
33.9
10.4
13
*
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
5.0
10.3
33
73
X59
ICD-10 Finland
Exposure to unspecified factor
2.8
10.2
74
317
SPAT1215
SPAT
Assessment of need for medical rehabilitation
5.6
10.2
29
56
PEH56
NOMESCO Finland
Bypass from femoral to popliteal artery above knee
15.3
10.1
16
11
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
6.1
10.1
27
48
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
41.6
10.0
12
*
K92
ICPC
Atherosclerosis/periph vascular dis
11.2
9.9
18
17
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
11.2
9.9
18
17
L04AD01
ATC
ciclosporin; systemic
20.9
9.9
14
7
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
5.0
9.9
31
67
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
7.2
9.8
23
34
205
Kela drug reimbursment
Chronic hypertension
2.4
9.8
109
588
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
5.2
9.8
30
63
B99
ICD-10 Finland
Other and unspecified infectious diseases
14.0
9.8
16
12
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
4.7
9.8
33
77
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
3.4
9.7
49
164
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.9
9.6
40
114
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
6.6
9.6
24
39
I50.0
ICD-10 Finland
Congestive heart failure
4.0
9.6
38
104
B01AB05
ATC
enoxaparin; parenteral
2.4
9.6
102
537
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
8.5
9.5
20
25
I74.3
ICD-10 Finland
Embolism and thrombosis of arteries of lower extremities
12.9
9.5
16
13
A10AB06
ATC
insulin glulisine; parenteral
31.1
9.5
12
*
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
31.1
9.5
12
*
NDQ20
NOMESCO Finland
Amputation of finger
31.1
9.5
12
*
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
31.1
9.5
12
*
QDG10
NOMESCO Finland
Excision and repair of bedsore of lower limb
103.2
9.5
10
*
T93.6
ICD-10 Finland
Sequelae of crushing injury and traumatic amputation of lower limb
103.2
9.5
10
*
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
9.1
9.4
19
22
PB1AC
NOMESCO Finland
Angiography of upper extremity with X-ray
+∞
9.4
9
*
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
+∞
9.4
9
*
C02CA01
ATC
prazosin; oral
10.0
9.4
18
19
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
8.7
9.2
19
23
WX400
NOMESCO Finland
Inhalation anesthesy
5.8
9.1
25
46
E87.5
ICD-10 Finland
Hyperkalaemia
16.2
9.1
14
9
S19
ICPC
Skin injury other
6.1
9.1
24
42
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.1
9.1
151
971
D64.9
ICD-10 Finland
Anaemia, unspecified
3.2
9.1
50
177
WZC30
NOMESCO Finland
Teaching
3.1
9.1
54
201
SPAT1254
SPAT
Administration of medicine
2.9
9.0
61
247
S17
ICPC
Abrasion/scratch/blister
9.1
8.9
18
21
C10AA05
ATC
atorvastatin; oral
2.2
8.8
126
756
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.0
8.7
27
58
L03.0
ICD-10 Finland
Cellulitis of finger and toe
4.4
8.7
31
77
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.3
8.6
101
551
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.5
8.5
76
360
S72.4
ICD-10 Finland
Fracture of lower end of femur
20.8
8.5
12
6
N02BE01
ATC
paracetamol; systemic, rectal
2.5
8.5
249
2021
E10
ICD-10 Finland
Type 1 diabetes mellitus
13.3
8.5
14
11
QWC00
NOMESCO Finland
Reoperation for superficial infection in surgery of skin
92.6
8.5
9
*
M04AA01
ATC
allopurinol; systemic
2.8
8.4
58
238
K28
ICPC
Limited function/disability (K)
8.9
8.4
17
20
L98
ICPC
Acquired deformity of limb
+∞
8.4
8
*
NHQ60
NOMESCO Finland
Revision of ampution or exarticulation of ankle or foot
+∞
8.4
8
*
M86.0
ICD-10 Finland
Acute haematogenous osteomyelitis
+∞
8.4
8
*
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
5.7
8.3
23
43
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
6.0
8.3
22
39
R50.9
ICD-10 Finland
Fever, unspecified
2.7
8.3
58
241
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.8
8.3
27
61
N06AA09
ATC
amitriptyline; systemic
3.3
8.3
43
147
K08.3
ICD-10 Finland
Retained dental root
3.7
8.3
36
107
AN1
HP
Coronary angiography
3.1
8.3
46
164
Z01.8
ICD-10 Finland
Other specified special examinations
2.5
8.2
72
337
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.7
8.2
62
267
I50.1
ICD-10 Finland
Left ventricular failure
4.7
8.2
27
62
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
6.6
8.2
20
32
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.2
8.2
21
36
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
34.4
8.1
10
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.6
8.1
36
109
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.4
8.0
28
68
ZZR00
NOMESCO Finland
Flap of skin
8.1
8.0
17
22
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.4
8.0
38
122
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
13.5
8.0
13
10
EBA15
NOMESCO Finland
Extraction of large number of teeth
5.3
7.9
23
46
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.3
7.9
18
26
Z04.3
ICD-10 Finland
Examination and observation following other accident
7.3
7.9
18
26
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
11.2
7.9
14
13
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
11.2
7.9
14
13
I20.09
ICD-10 Finland
Unstable angina
4.7
7.9
26
60
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
6.2
7.8
20
34
WX199
NOMESCO Finland
Other local analgesia
6.2
7.8
20
34
A10AE06
ATC
insulin degludec; parenteral
7.8
7.8
17
23
WX882
NOMESCO Finland
High dependency care
5.2
7.8
23
47
PFH63
NOMESCO Finland
Bypass from femoral or popliteal artery to distal posterior tibial artery
46.2
7.8
9
*
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
46.2
7.8
9
*
H3600, E113
ICD-10 Finland
NA
8.4
7.7
16
20
JN3AD
NOMESCO Finland
Abdominal CT examination
3.5
7.7
36
114
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
5.7
7.7
21
39
TQW40
NOMESCO Finland
Remowal of suture of skin
3.8
7.7
32
92
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
6.5
7.7
19
31
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.9
7.7
31
87
B03XA01
ATC
erythropoietin; parenteral
19.0
7.7
11
6
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
3.7
7.6
32
93
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.7
7.5
24
54
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
7.5
36
117
PWG00
NOMESCO Finland
Reoperation on peripheral vessels for thrombosis or embolism
82.1
7.5
8
*
ZZQ30
NOMESCO Finland
Free microvascular graft of muscle
82.1
7.5
8
*
M86.2
ICD-10 Finland
Subacute osteomyelitis
82.1
7.5
8
*
PFH59
NOMESCO Finland
Bypass from femoral or popliteal artery to distal anterior tibial artery
82.1
7.5
8
*
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
82.1
7.5
8
*
J01CF05
ATC
flucloxacillin; systemic
5.2
7.5
22
45
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
13.8
7.4
12
9
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.0
7.4
136
885
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
7.4
117
719
C03DA01
ATC
spironolactone; oral
3.0
7.4
42
153
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
9.7
7.4
14
15
A10BH05
ATC
linagliptin; oral
4.7
7.3
24
55
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
+∞
7.3
7
*
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
+∞
7.3
7
*
QWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of skin
+∞
7.3
7
*
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.3
7.3
26
65
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
7.6
7.3
16
22
L04AA01
ATC
[U] ciclosporin; systemic
16.2
7.3
11
7
E0000UV
ATC
NA
2.0
7.3
112
681
SPAT1260
SPAT
Consultation of another employee
2.5
7.3
64
299
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.8
7.3
23
51
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.9
7.2
45
174
ZX120
NOMESCO Finland
Intravenous
3.2
7.2
38
132
A10BB07
ATC
glipizide; oral
8.3
7.2
15
19
WX725
NOMESCO Finland
Noninvasive ventilation
4.2
7.2
26
66
J01XX08
ATC
linezolid; systemic
30.8
7.2
9
*
NH1DG
NOMESCO Finland
Ankle and foot very extensive MRI examination with high intensity magnet
30.8
7.2
9
*
H05BX01
ATC
cinacalcet; oral
20.6
7.2
10
5
A07AA09
ATC
vancomycin; oral
12.4
7.1
12
10
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.9
7.1
44
168
C08CA01
ATC
amlodipine; oral
2.0
7.1
115
710
T79.3
ICD-10 Finland
Post-traumatic wound infection, not elsewhere classified
10.4
7.1
13
13
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
10.4
7.1
13
13
I10
ICD-10 Finland
Essential (primary) hypertension
1.9
7.1
178
1296
WX002
NOMESCO Finland
Sedation and analgesia
2.4
7.1
64
306
S76
ICPC
Skin infection other
4.3
7.1
25
62
XF600
NOMESCO Finland
Bloodpressure measurement
3.8
7.0
29
83
S21
ICPC
Skin texture symptom/complaint
2.8
7.0
44
171
WX892
NOMESCO Finland
Monitored bed care
3.1
7.0
37
129
TNX39
NOMESCO Finland
Other orthopedic bandage, unspecified region
14.2
6.9
11
8
C10AA01
ATC
simvastatin; oral
1.9
6.9
139
928
L99
ICPC
Musculoskeletal disease other
8.6
6.9
14
17
H04AA01
ATC
glucagon; nasal, parenteral
8.6
6.9
14
17
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.5
6.9
57
258
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
6.8
87
486
Z02.7
ICD-10 Finland
Issue of medical certificate
3.9
6.8
27
75
A87
ICPC
Complication of medical treatment
17.2
6.8
10
6
J01CF01
ATC
dicloxacillin; systemic
41.0
6.8
8
*
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
41.0
6.8
8
*
TK820
NOMESCO Finland
Peritoneal dialysis
41.0
6.8
8
*
PEF24
NOMESCO Finland
Thrombendarterectomy of deep femoral artery
41.0
6.8
8
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.1
6.8
95
553
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.0
6.7
39
144
WX306
NOMESCO Finland
Lumbar epidural anesthesy
4.8
6.7
21
46
I20.01
ICD-10 Finland
Unstable angina
6.7
6.7
16
25
A10AD04
ATC
insulin lispro; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
23.1
6.7
9
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.2
6.7
24
61
C08CA02
ATC
felodipine; oral
2.8
6.6
43
171
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.7
6.6
28
82
N02AJ06
ATC
codeine and paracetamol; systemic
2.0
6.6
106
649
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
9.0
6.6
13
15
L04AX01
ATC
azathioprine; systemic
5.3
6.6
19
38
S09
ICPC
Infected finger/toe
5.6
6.6
18
34
WX290
NOMESCO Finland
Other blockade of nerve
1.9
6.6
122
787
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.5
6.5
29
89
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.6
6.5
50
218
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
7.7
6.5
14
19
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.8
6.5
26
73
2507B
ICD-9 Finland
Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]
71.3
6.5
7
*
RJ414
NOMESCO Finland
NA
71.3
6.5
7
*
NH3BG
NOMESCO Finland
MRI of foot
71.3
6.5
7
*
2504B
ICD-9 Finland
Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]
71.3
6.5
7
*
H28.0*E10.3
ICD-10 Finland
Other specified diabetes mellitus - Diabetic cataract
71.3
6.5
7
*
S78.1
ICD-10 Finland
Traumatic amputation at level between hip and knee
71.3
6.5
7
*
NH3CG
NOMESCO Finland
Extensive MRI of foot
14.7
6.4
10
7
H3600, E103
ICD-10 Finland
NA
14.7
6.4
10
7
G63.2
ICD-10 Finland
Diabetic polyneuropathy
14.7
6.4
10
7
NHG20
NOMESCO Finland
Fusion of talocrural joint
14.7
6.4
10
7
SPAT1310
SPAT
Counselling related to known health issue
2.0
6.4
94
555
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.4
6.4
30
96
N05BA04
ATC
oxazepam; oral
2.2
6.4
75
403
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
4.1
6.3
23
59
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
11.4
6.3
11
10
K65.0
ICD-10 Finland
Acute peritonitis
11.4
6.3
11
10
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
11.4
6.3
11
10
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.4
6.3
57
271
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
9.6
6.3
12
13
NGM10
NOMESCO Finland
Fasciotomy of of knee or lower leg
18.5
6.3
9
5
EBA10
NOMESCO Finland
Surgical removal of tooth
3.0
6.3
36
132
PG1ST
NOMESCO Finland
Endovascular arterial thrombolysis with radiological guidance not elsewhere classified
+∞
6.3
6
*
S98.1
ICD-10 Finland
Traumatic amputation of one toe
+∞
6.3
6
*
Z89.9
ICD-10 Finland
Acquired absence of limb, unspecified
+∞
6.3
6
*
PD4HE
NOMESCO Finland
Postoperative lower extremity artery ultrasound examination with Doppler method
+∞
6.3
6
*
CM2S4
NOMESCO Finland
Follow-up photography of age-related macular degeneration lesions
+∞
6.3
6
*
25008
ICD-8 Finland
Diabetes mellitus, Complicatio alia definita
+∞
6.3
6
*
PFH67
NOMESCO Finland
Bypass from femoral or popliteal artery to posterior tibial artery in foot
+∞
6.3
6
*
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
+∞
6.3
6
*
ND2CG
NOMESCO Finland
Extensive MRI of hand
+∞
6.3
6
*
PEQ23
NOMESCO Finland
Insertion of endovascular graft into femoral artery
+∞
6.3
6
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.8
6.2
40
158
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.7
6.2
41
165
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.7
6.2
43
177
E000006
ATC
NA
3.7
6.2
26
76
N19
ICD-10 Finland
Unspecified kidney failure
4.6
6.2
20
46
S01BC05
ATC
ketorolac; ophthalmic
5.1
6.2
18
37
C02AC05
ATC
moxonidine; oral
4.0
6.1
23
61
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
8.9
6.1
12
14
R4110
SPAT
NA
5.4
6.1
17
33
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.1
6.1
31
106
J01DA01
ATC
[U] cefalexin; systemic
1.8
6.1
182
1374
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
144
290
8.10
75.93
4.5
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
78
91
10.95
64.33
2.7
1.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
146
371
6.32
58.93
6.5
2.0
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
102
185
7.57
57.90
24.8
6.2
mmol/l
15.1
10.3
6.10
94
174
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
71
84
10.53
57.68
2.4
1.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
122
298
5.94
50.47
22.7
5.0
mmol/l
1.3
1.0
9.47
111
274
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
88
157
7.31
50.25
6.7
3.2
mmol/l
1.2
1.6
0.32
60
121
(3022313) Gas panel - Capillary blood
77
119
8.16
50.11
6.8
3.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
90
167
7.06
49.44
6.9
3.1
kpa
5.0
5.2
0.67
83
153
(3009343) pH of Capillary blood
89
164
7.09
49.21
6.9
3.1
ph
7.4
7.4
—
6
17
(3019225) pH of Specimen
99
212
6.27
46.88
12.6
4.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
63
104
7.27
38.16
7.7
3.5
mmol/l
24.4
25.0
0.55
57
97
(3022948) Iron [Moles/volume] in Serum or Plasma
122
370
4.67
37.70
7.4
2.3
umol/l
10.0
13.2
4.67
114
342
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
79
168
5.89
37.10
2.2
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
179
729
4.23
36.89
10.2
4.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
104
286
4.87
36.21
3.1
4.2
u/l
243.4
237.4
0.15
93
266
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
127
417
4.35
34.99
2.9
1.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
113
341
4.54
34.81
7.7
2.3
g/l
2.0
2.3
4.11
107
311
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
65
122
6.41
34.64
1.8
1.7
g/l
1.9
1.6
1.17
58
108
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
72
156
5.64
32.91
12.5
3.7
ng/l
205.1
80.5
4.95
60
135
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
107
328
4.37
31.99
7.6
2.4
%
19.3
23.2
2.32
87
285
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
143
558
3.78
30.07
7.2
2.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
83
221
4.70
29.59
6.6
2.4
e9/l
72.9
66.5
1.03
76
176
(3044640) Blood type and Crossmatch panel - Blood
171
767
3.59
28.71
6.8
2.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
214
1114
3.68
28.19
10.8
3.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
35
41
9.44
28.04
1.7
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
53
104
5.89
26.71
2.7
1.8
ug/l
4.1
4.9
0.09
47
91
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
81
231
4.34
26.21
2.8
2.2
g/l
0.2
0.2
0.29
75
213
(3012095) Magnesium [Moles/volume] in Serum or Plasma
107
374
3.77
25.99
6.7
3.0
mmol/l
0.8
0.8
0.87
99
348
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
141
598
3.39
25.20
3.8
2.1
mg/l
3.3
3.1
0.33
128
516
(3027945) Reticulocytes/100 erythrocytes in Blood
92
308
3.77
23.59
6.2
2.3
%
2.0
1.8
1.55
85
282
(3047181) Lactate [Moles/volume] in Blood
42
76
6.20
22.91
9.1
5.4
mmol/l
1.5
1.4
0.22
37
65
(3013512) EKG study
153
714
3.15
22.80
7.0
3.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
189
1006
3.09
22.13
21.4
8.1
inr
1.3
1.3
0.13
37
275
(3002179) Metamyelocytes/100 leukocytes in Blood
60
155
4.52
21.85
3.8
4.3
%
0.5
0.4
0.35
23
45
(42870588) Differential panel, method unspecified - Blood
160
784
3.04
21.60
10.7
5.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
30
41
7.96
21.14
3.7
3.8
%
1.5
1.1
0.27
21
31
(3024561) Albumin [Mass/volume] in Serum or Plasma
192
1062
2.97
20.43
17.1
4.5
g/l
31.1
35.0
12.44
182
988
(3017181) Myelocytes/100 leukocytes in Blood
63
181
4.07
19.85
4.1
4.3
%
0.7
0.8
0.24
32
69
(3019309) Folate [Moles/volume] in Red Blood Cells
112
469
3.11
19.65
2.1
1.8
nmol/l
1125.3
1199.5
0.35
86
354
(3017354) Segmented neutrophils/100 leukocytes in Blood
23
25
9.82
19.31
3.4
3.3
%
61.6
60.1
0.06
15
16
(3022217) INR in Platelet poor plasma by Coagulation assay
85
311
3.34
18.60
28.0
22.0
inr
1.4
1.3
0.34
36
36
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
81
5.33
18.30
5.2
2.6
u/ml
0.4
0.4
0.02
23
43
(3008757) Leukocyte morphology finding [Identifier] in Blood
23
27
9.09
18.23
3.4
4.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
154
794
2.78
18.13
7.0
3.9
mg/mmol
36.9
9.1
3.67
123
521
(3021440) Promyelocytes/100 leukocytes in Blood
58
168
3.98
17.99
4.1
4.4
%
0.0
0.2
1.28
30
60
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
83
306
3.30
17.88
6.1
4.5
%
31.4
30.7
0.22
73
197
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
34
65
5.72
17.43
1.4
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
195
1160
2.69
16.89
29.2
6.2
mmol/l
1.2
1.2
1.00
172
982
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
204
1242
2.72
16.84
11.4
6.4
umol/l
9.2
12.1
6.83
195
1182
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
146
756
2.69
16.73
5.3
2.5
u/l
48.8
55.9
1.20
137
701
(3022096) Basophils/100 leukocytes in Blood
184
1071
2.65
16.55
11.1
5.4
%
0.6
0.6
0.96
175
990
(3012516) Albumin [Mass/volume] in Urine
144
744
2.68
16.53
5.8
3.2
mg/l
207.4
144.6
0.31
120
507
(3006504) Eosinophils/100 leukocytes in Blood
187
1100
2.64
16.41
11.5
5.5
%
2.9
3.0
0.18
177
1017
(3018010) Neutrophils/100 leukocytes in Blood
188
1110
2.64
16.35
11.2
5.4
%
63.5
58.1
7.00
175
1034
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
24
34
7.54
16.33
1.1
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
19
20
10.03
16.26
5.6
2.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
149
789
2.64
16.19
6.0
3.0
mmol/l
6.2
8.2
8.05
131
652
(3019069) Monocytes/100 leukocytes in Blood
187
1106
2.62
16.14
12.8
5.8
%
8.3
8.8
1.06
176
1027
(3014271) Vancomycin [Susceptibility]
15
11
14.25
16.02
3.1
2.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
62
203
3.54
16.01
2.9
2.4
ug/l
5.2
6.7
0.47
54
170
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
28
49
6.16
15.67
1.3
1.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
189
1134
2.59
15.67
11.9
5.6
%
21.2
26.7
8.58
177
1047
(3026008) Bacteria identified in Urine by Culture
133
677
2.63
15.54
4.4
3.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
52
158
3.73
14.97
1.6
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
18
20
9.47
14.79
1.2
1.1
u/l
55.4
61.7
—
5
11
(3001122) Ferritin [Mass/volume] in Serum or Plasma
165
949
2.50
14.68
7.1
2.6
ug/l
236.4
143.9
2.97
157
863
(3037121) Protein [Mass/volume] in Urine
34
76
4.88
14.61
4.3
4.2
g/l
0.6
0.2
1.96
23
31
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
20
26
8.13
14.58
1.3
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
20
26
8.13
14.58
1.3
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
20
26
8.13
14.58
1.3
1.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
190
1169
2.50
14.54
9.7
5.5
e9/l
0.0
0.0
1.26
175
1017
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
169
990
2.47
14.35
2.5
2.0
pmol/l
97.7
93.7
0.45
102
509
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
32
69
5.03
14.33
2.8
1.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
138
738
2.51
14.29
3.5
2.1
u/l
217.2
340.2
0.56
132
693
(3013115) Eosinophils [#/volume] in Blood
193
1210
2.46
13.97
10.2
5.5
e9/l
0.2
0.2
0.88
177
1073
(3001604) Monocytes [#/volume] in Blood
188
1165
2.45
13.97
9.5
5.5
e9/l
0.7
0.6
3.27
172
1006
(3013826) Glucose [Moles/volume] in Serum or Plasma
218
1445
2.54
13.95
13.5
4.2
mmol/l
8.4
6.9
9.15
211
1355
(3019198) Lymphocytes [#/volume] in Blood
191
1197
2.44
13.77
9.7
5.5
e9/l
1.7
1.9
0.90
175
1061
(3002032) Base excess in Venous blood by calculation
64
234
3.16
13.74
15.3
3.3
mmol/l
1.2
2.0
0.81
51
175
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
34
80
4.63
13.73
1.2
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
135
726
2.47
13.68
4.7
2.8
ng/l
6188.7
1414.9
3.10
120
608
(3015235) Bicarbonate [Moles/volume] in Capillary blood
30
64
5.06
13.59
4.4
2.4
mmol/l
21.8
24.6
2.02
25
53
(3025468) Yersinia sp identified in Specimen by Organism specific culture
19
26
7.70
13.26
1.3
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
17
21
8.49
12.87
1.1
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
37
98
4.13
12.85
3.3
2.9
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
19
27
7.41
12.84
1.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
19
27
7.41
12.84
1.3
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
51
169
3.39
12.81
2.3
2.3
g/l
11.5
10.7
0.45
43
151
(3025159) Blasts/100 leukocytes in Blood
48
154
3.48
12.67
4.5
4.6
%
0.0
0.0
0.00
25
48
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
150
869
2.34
12.62
4.1
2.2
nmol/l
73.0
74.5
0.26
132
755
(3026493) Urate [Moles/volume] in Serum or Plasma
123
656
2.41
12.48
4.5
2.7
umol/l
380.4
9537.3
3.65
111
571
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22
40
5.83
11.81
2.8
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
61
237
2.94
11.69
3.1
1.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
20
34
6.20
11.47
2.6
1.2
u/ml
122.7
104.2
—
6
8
(3018677) aPTT in Platelet poor plasma by Coagulation assay
84
391
2.55
11.31
3.0
2.0
s
30.9
29.5
0.87
78
381
(3028026) IgM [Mass/volume] in Serum or Plasma
41
129
3.49
11.12
1.8
1.7
g/l
1.0
1.6
0.64
35
117
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
26
59
4.70
10.94
1.8
1.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
200
1361
2.21
10.82
13.6
9.0
e9/l
5.6
4.3
5.44
183
1189
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
65
275
2.70
10.56
3.1
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
24
53
4.81
10.42
2.3
5.8
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
20
38
5.54
10.24
1.5
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
25
58
4.59
10.24
1.8
1.9
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
18
8.08
10.22
1.1
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
247
1859
2.36
10.08
18.7
7.4
u/l
93.5
79.3
3.03
236
1727
(46235355) HIV 1 and 2 tests - Meaningful Use set
73
336
2.51
9.96
3.2
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
45
163
3.04
9.69
4.3
2.6
e9/l
4.6
4.1
0.47
28
130
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
11
10.31
9.59
1.3
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
9
0
+∞
9.42
5.4
0.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
25
63
4.21
9.23
1.4
1.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
16
27
6.18
9.21
7.9
2.1
mg/l
14.6
17.2
—
7
7
(3004588) Protein electrophoresis panel - Serum or Plasma
46
174
2.91
9.17
2.1
2.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
38
129
3.20
9.12
15.1
7.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
163
1073
2.04
9.05
18.5
5.4
mmol/l
1.2
1.2
0.58
146
967
(3034860) Kappa light chains.free [Mass/volume] in Serum
28
78
3.83
9.05
2.1
4.8
mg/l
88.3
79.0
0.14
23
63
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
28
78
3.83
9.05
2.1
4.8
mg/l
54.7
37.3
0.57
22
65
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
42
153
3.00
8.95
1.8
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
43
4.89
8.95
1.8
1.8
—
—
—
0
0
(3017704) Immunofixation for Urine
12
15
8.27
8.92
1.8
1.7
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
13
8
16.85
8.62
2.8
2.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
12
6
20.68
8.53
2.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
15
26
6.00
8.40
1.3
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
52
220
2.62
8.37
3.9
2.6
g/l
65.0
66.2
0.42
46
199
(3003396) Base excess in Arterial blood by calculation
63
293
2.43
8.32
11.9
6.1
mmol/l
1.9
1.1
0.96
47
223
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
17
34
5.22
8.23
1.6
2.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
11
9.35
8.12
1.3
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
17
7.29
8.05
1.2
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
62
295
2.36
7.76
2.2
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
18
40
4.70
7.75
1.9
1.9
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
17
36
4.93
7.73
1.6
1.3
mmol/l
44.4
61.5
1.80
11
31
(3000991) Gas panel - Venous blood
48
203
2.60
7.72
14.3
6.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
88
485
2.12
7.70
8.5
3.6
ng/l
133.0
251.5
0.56
72
390
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
18
6.88
7.66
2.3
2.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
12
8.57
7.62
1.0
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
19
45
4.42
7.58
4.3
2.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
13
22
6.11
7.43
1.8
2.4
e9/l
0.7
0.9
—
6
11
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
34
782
0.37
7.42
3.2
3.0
ug/l
0.9
0.8
0.54
28
527
(3037467) Urinalysis macro (dipstick) panel - Urine
218
1655
1.96
7.40
8.6
4.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
0
+∞
7.32
6.7
0.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
17
38
4.66
7.26
1.5
1.2
u/ml
297.8
301.9
0.02
12
21
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
210
1581
1.92
7.23
7.4
3.0
u/l
84.9
52.8
2.65
197
1471
(3020876) Protein [Mass/time] in 24 hour Urine
13
23
5.85
7.12
1.5
2.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
21
57
3.87
7.03
2.3
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
225
1749
1.92
6.84
8.4
4.0
mm/h
25.1
12.3
11.84
214
1597
(3015377) Calcium [Moles/volume] in Serum or Plasma
123
791
1.89
6.82
7.0
3.2
mmol/l
2.3
2.3
3.63
105
682
(3031040) Bacteria [#/volume] in Urine by Automated count
208
1583
1.87
6.68
7.1
4.2
—
2516.2
—
0
34
(3037522) Nuclear Ab [Titer] in Serum
57
279
2.26
6.64
1.5
1.3
titre
711.4
508.9
0.23
14
61
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
120
772
1.88
6.61
4.2
3.3
u/l
35.7
34.7
0.08
112
734
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
85
489
2.00
6.51
1.9
1.6
mg/l
1.2
1.3
0.25
68
390
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
87
506
1.98
6.46
1.8
1.7
pmol/l
467.8
22823941.1
0.79
70
425
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
15
6.85
6.34
2.3
2.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
15
6.85
6.34
1.0
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
9
5
18.45
6.30
1.1
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
32
122
2.80
6.27
1.3
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
0
+∞
6.27
1.0
0.0
—
—
—
0
0
(3024471) HLA-A [Type]
6
0
+∞
6.27
1.0
0.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
20
58
3.61
6.11
1.3
1.1
—
66.0
—
0
5
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
141
975
1.79
6.02
7.3
3.4
ng/l
87.7
55.1
0.88
119
683
(3019060) Gas panel - Arterial blood
39
169
2.49
5.95
10.3
4.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
30
114
2.80
5.92
10.8
3.3
mmol/l
23.7
24.2
0.36
25
99
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
45
3.93
5.89
1.5
2.0
—
—
—
0
0
(4146454)
12
24
5.15
5.79
3.5
3.0
—
—
—
0
0
(44790047)
13
28
4.79
5.78
1.8
1.7
—
—
—
0
0
(44790049)
13
28
4.79
5.78
1.8
1.7
—
—
—
0
0
(44806118)
13
28
4.79
5.78
1.8
1.7
—
—
—
0
0
(44790048)
13
28
4.79
5.78
1.8
1.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
93
573
1.87
5.74
2.0
1.5
nmol/l
20.3
20.4
0.01
80
476
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
21
5.39
5.56
1.5
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
24
568
0.38
5.35
4.4
3.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
14
35
4.13
5.22
1.6
2.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
14
35
4.13
5.22
1.0
1.0
iu/ml
1.4
18.6
—
7
7
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
9
10.24
5.05
1.2
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
9
10.24
5.05
1.2
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
48
850
0.49
5.05
4.0
2.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
28
4.41
4.86
1.4
2.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
37
3.91
4.86
1.7
1.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
11
24
4.71
4.81
1.5
1.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
45
229
2.12
4.74
7.2
5.4
mmol/l
1.3
1.5
0.39
39
214
(3027456) Digoxin [Moles/volume] in Serum or Plasma
16
48
3.45
4.67
2.6
3.1
nmol/l
1.0
0.9
—
7
39
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
30
4.11
4.47
1.4
2.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
54
306
1.92
4.23
2.8
1.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
13
7.08
4.19
1.1
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
62
369
1.84
4.17
1.3
1.3
iu/ml
72.6
35.9
0.31
12
117
(3006184) Hemoglobin [Mass/volume] in Capillary blood
17
58
3.04
4.07
3.1
1.9
g/l
111.5
131.7
1.80
11
40
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
46
250
1.98
4.06
9.9
3.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
14
43
3.36
3.95
7.3
3.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
11
7.42
3.88
1.8
2.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
11
7.42
3.88
2.8
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
11
7.42
3.88
1.8
2.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
11
7.42
3.88
1.8
2.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
11
7.42
3.88
1.8
2.2
—
—
—
0
0
(3044889) 12 lead EKG panel
137
1735
0.64
3.84
5.7
3.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
74
1081
0.59
3.82
4.0
4.3
%
25.7
21.5
1.16
34
528
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
8
8.91
3.79
1.7
2.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
8
8.91
3.79
1.7
2.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
8
8.91
3.79
1.7
2.6
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
6
10.15
3.51
2.8
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
77
515
1.65
3.41
4.5
2.8
mosm/kgh2o
469.7
594.2
6.85
68
438
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
10
7.13
3.38
1.1
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
43
3.11
3.29
7.4
2.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
197
0.29
3.20
1.0
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
57
358
1.72
3.19
1.2
1.3
u/ml
10.6
14.5
0.15
21
141
(3007164) IgA [Mass/volume] in Serum or Plasma
64
415
1.67
3.18
1.7
1.3
g/l
3.5
2.6
0.81
50
242
(3028308) Erythrocytes [#/volume] in Pleural fluid
11
34
3.31
3.08
1.3
1.2
e6/l
110372.6
22019.7
—
5
18
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
29
3.53
3.07
1.3
1.9
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
16
5.10
3.07
1.1
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
8
7.61
3.06
3.3
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
23
108
2.22
2.98
1.2
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
50
310
1.72
2.93
2.8
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
89
638
1.54
2.92
1.4
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
13
5.48
2.88
1.0
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
9
6.77
2.88
1.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
15
59
2.62
2.83
1.6
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
23
3.99
2.79
1.2
1.4
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
6
8.44
2.76
1.8
1.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
6
8.44
2.76
4.2
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
16
66
2.50
2.75
1.5
1.6
ug/g
280.1
272.0
—
9
37
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
268
2418
1.61
2.75
65.7
14.4
mg/l
32.1
27.2
2.15
246
1916
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
10
262
0.36
2.74
1.1
1.6
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
6
10
6.09
2.71
1.0
1.4
umol/l
10.8
27.6
—
6
10
(3006270) Folate [Moles/volume] in Blood
9
24
3.83
2.69
1.2
1.2
nmol/l
373.0
363.7
—
9
19
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
43
2.86
2.67
1.8
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
43
2.86
2.67
1.7
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
43
2.86
2.67
1.7
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
49
310
1.68
2.67
1.3
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
7
7.23
2.55
1.0
2.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
33
3.09
2.55
2.5
3.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
18
82
2.26
2.52
3.4
2.5
ug/min
197.5
104.9
0.48
11
47
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
177
0.33
2.48
1.3
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
30
168
1.87
2.46
1.4
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
12
5.07
2.41
1.8
1.1
iu/ml
399.3
251.7
—
6
12
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
8
6.33
2.38
1.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
8
6.33
2.38
1.0
1.6
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
8
6.33
2.38
1.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
8
6.33
2.38
1.0
1.1
—
—
—
0
0
(4015189)
5
8
6.33
2.38
3.6
1.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
35
2.92
2.32
1.1
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
13
4.68
2.28
40.0
11.8
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
9
5.62
2.22
1.6
2.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
42
2.68
2.21
1.1
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
24
3.39
2.19
1.8
2.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
24
3.39
2.19
1.8
2.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
24
3.39
2.19
1.8
2.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
19
3.74
2.16
1.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
10
5.06
2.08
1.0
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
9
205
0.42
2.03
1.3
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
32
2.86
2.01
2.1
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
116
935
1.37
1.96
2.1
2.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
16
3.80
1.94
6.2
2.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
117
946
1.37
1.94
6.1
3.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
9
34
2.69
1.88
1.4
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
45
307
1.54
1.83
2.3
2.5
umol/l
8.3
9.5
0.25
37
279
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
35
2.62
1.81
1.0
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
102
1.92
1.80
1.7
2.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
102
1.92
1.80
1.7
2.0
g/l
4.4
3.8
0.57
13
80
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
102
1.92
1.80
1.7
2.0
g/l
8.7
7.5
1.23
13
83
(3021879) Hepatitis B virus core Ab [Presence] in Serum
25
148
1.75
1.76
1.6
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
18
3.38
1.75
1.0
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
18
3.38
1.75
1.0
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
18
3.38
1.75
1.5
2.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
48
2.34
1.72
1.2
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
13
3.89
1.72
1.4
2.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
47
0.00
1.72
0.0
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
97
1.91
1.69
1.7
2.1
g/l
3.3
3.3
0.03
13
81
(3035880) pH of Pleural fluid
6
19
3.20
1.67
1.2
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
19
3.20
1.67
1.3
1.5
—
—
—
0
0
(3000492) Spirometry study
11
222
0.48
1.65
1.5
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
24
144
1.72
1.62
2.4
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
14
3.61
1.62
1.4
2.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
26
2.73
1.59
1.6
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
20
3.04
1.59
1.5
2.0
—
—
—
0
0
(4035726)
32
209
1.59
1.58
1.6
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
48
651
0.69
1.56
5.3
3.8
estimate
0.0
0.0
0.00
20
196
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
44
2.31
1.54
1.2
1.2
—
0.9
—
0
5
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
51
2.20
1.52
1.4
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
38
2.41
1.46
1.3
1.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
14
73
1.96
1.46
4.3
4.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
28
2.53
1.46
1.4
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
21
126
1.71
1.44
2.6
2.3
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
7
29
2.44
1.40
4.3
2.3
mmol/l
1.4
1.5
—
7
29
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
61
467
1.38
1.39
1.5
1.2
u/ml
4.5
0.8
0.72
12
122
(3035637) Corticotropin [Mass/volume] in Plasma
5
17
2.97
1.36
1.0
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
37
0.00
1.35
0.0
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
243
2251
1.31
1.33
13.2
6.0
mmol/mol
48.8
40.6
12.46
225
2066
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
76
933
0.76
1.31
5.8
3.8
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
8
34
2.39
1.30
2.1
2.6
%
79.4
62.5
—
8
34
(3024928) Oxygen saturation in Venous blood
10
48
2.12
1.29
3.2
2.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
270
2543
1.36
1.29
64.8
16.3
mmol/l
138.7
139.7
6.98
263
2479
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
157
1383
1.26
1.28
3.7
2.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
25
2.43
1.25
6.3
3.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
270
2548
1.35
1.23
66.6
16.4
mmol/l
4.1
4.0
6.91
263
2485
(3035350) Ketones [Presence] in Urine by Test strip
101
1181
0.79
1.17
5.2
3.6
estimate
0.0
0.0
0.00
25
209
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
33
0.00
1.17
0.0
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
33
0.00
1.17
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
33
0.00
1.17
0.0
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
33
0.00
1.17
0.0
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
33
0.00
1.17
0.0
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
13
72
1.84
1.17
5.8
3.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
27
185
1.50
1.12
6.8
2.6
ml/min/173m2
47.9
67.9
1.31
14
75
(40761535) Cells panel - Urine sediment
28
194
1.48
1.11
4.7
3.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
31
2.28
1.11
6.1
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
68
550
1.30
1.09
5.0
2.6
e6/l
7.0
4.4
1.32
63
488
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
32
2.21
1.08
1.7
1.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
57
710
0.76
1.08
6.5
3.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
18
113
1.63
1.08
1.2
1.2
iu/ml
55.5
100.4
—
6
45
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
24
162
1.52
1.07
2.0
2.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
39
292
1.38
1.04
2.1
1.9
%
1.8
1.6
0.83
31
249
(40768806) Pleura Pathology biopsy report
7
34
2.08
1.03
1.7
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
43
553
0.74
1.02
5.2
3.9
kg/l
1.0
1.0
1.75
15
77
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
12
68
1.79
1.02
1.6
1.8
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
9
48
1.90
1.01
2.7
2.8
mmol/l
105.4
104.9
—
9
48
(3041354) Potassium [Moles/volume] in Venous blood
9
48
1.90
1.01
2.7
2.8
mmol/l
4.2
4.1
—
9
48
(3009261) Glucose [Presence] in Urine by Test strip
104
1195
0.81
1.00
5.4
3.6
estimate
0.0
0.0
0.00
23
197
(3022806) Fractional oxyhemoglobin in Capillary blood
5
23
2.19
0.98
4.6
2.3
%
88.1
90.0
—
5
23
(3005033) Fetal Nuchal fold Thickness US
0
30
0.00
0.97
0.0
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
30
0.00
0.97
0.0
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
102
1172
0.81
0.97
7.9
4.9
estimate
0.0
0.0
0.00
25
206
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
75
626
1.26
0.94
2.0
1.6
mmol/l
1.6
1.4
0.89
67
528
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
27
2.24
0.94
1.7
1.6
pg
33.5
33.2
—
6
27
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
64
1.74
0.87
1.7
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
226
2120
1.22
0.87
5.6
4.2
mu/l
2.0
2.0
0.04
210
1888
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
44
1.84
0.86
1.5
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
60
494
1.26
0.85
6.3
5.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
45
1.80
0.85
5.0
4.3
%
64.9
58.0
—
8
45
(3044941) Cell count panel - Synovial fluid
6
31
1.95
0.85
1.5
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
46
1.76
0.83
2.9
2.9
—
—
—
0
0
(3002256) Pathology report gross observation
40
313
1.32
0.83
1.2
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
25
181
1.41
0.83
2.0
2.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
18
122
1.50
0.82
2.2
3.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
35
447
0.76
0.81
4.1
2.8
e6/l
1.3
1.1
0.25
26
253
(3002582) Erythrocytes [#/volume] in Urine
93
809
1.21
0.80
5.7
3.3
e6/l
43.5
79.8
0.82
81
627
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3020891) Body temperature
5
99
0.50
0.79
24.0
4.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
27
0.00
0.78
0.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
27
0.00
0.78
0.0
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
4.4
—
3.4
—
0
28
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.1
—
2.1
—
0
10
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
269
2583
1.24
0.74
24.0
10.1
u/l
25.4
27.2
1.23
259
2484
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
13
84
1.57
0.73
1.0
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
36
284
1.30
0.72
3.3
4.6
ug/l
31.3
33.9
0.03
30
238
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
41
1.72
0.70
1.0
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
18
127
1.44
0.69
4.3
2.5
%
1.2
1.3
0.11
18
127
(21494890) Protein electrophoresis panel - 24 hour Urine
5
27
1.86
0.68
1.4
3.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
43
1.64
0.67
5.3
3.7
e9/l
4.3
4.4
—
7
43
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
28
1.80
0.66
1.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
10
63
1.61
0.62
1.9
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
21
157
1.36
0.61
4.4
2.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
52
1.55
0.60
4.6
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.0
—
8.0
—
0
13
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.0
—
0.9
—
0
10
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
226
2360
0.86
0.58
6.5
4.6
mmol/l
7.0
6.0
5.68
198
2127
(3021589) Normoblasts [#/volume] in Blood
94
1042
0.86
0.56
22.3
9.0
e9/l
0.0
0.0
1.06
78
840
(3048689) Calprotectin [Mass/mass] in Stool
32
258
1.27
0.56
1.5
2.2
ug/g
128.0
156.7
0.41
24
206
(3010421) pH of Blood
9
60
1.51
0.55
11.4
5.3
ph
7.4
7.4
—
9
45
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
178
1678
1.13
0.51
4.2
3.4
pmol/l
14.8
14.8
0.06
168
1488
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
47
1.50
0.48
1.9
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
15
198
0.75
0.47
8.2
3.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
31
1.62
0.43
1.4
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
123
1318
0.89
0.43
4.4
4.9
ug/l
1.9
2.8
1.79
107
1159
(40758558) Short blood count panel - Blood
52
590
0.86
0.43
8.9
6.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
59
1.36
0.41
2.5
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
4.0
—
24.8
—
0
5
(3035320) C reactive protein [Mass/volume] in Body fluid
0
18
0.00
0.40
0.0
1.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
10
71
1.42
0.39
1.6
1.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
35
1.44
0.39
1.2
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
67
1.35
0.38
4.3
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
115
0.69
0.37
1.6
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
69
1.31
0.37
4.3
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
69
1.31
0.37
5.3
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
30
352
0.84
0.37
1.5
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
66
728
0.88
0.37
18.3
4.0
ph
7.4
7.4
0.69
18
123
(3009542) Hematocrit [Volume Fraction] of Blood
213
2205
0.90
0.36
45.6
15.3
%
34.8
39.9
4.52
82
1563
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
41
1.47
0.36
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
45
1.34
0.34
1.2
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
72
659
1.12
0.33
5.7
3.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
47
1.28
0.32
9.5
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
66
1.22
0.27
4.6
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
35
311
1.14
0.26
12.7
7.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
81
0.74
0.24
1.0
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
5
38
1.32
0.23
1.6
1.9
g/l
0.7
1.0
—
5
29
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
15
125
1.21
0.23
1.1
1.4
—
54.2
—
0
11
(3030467) Casts [#/volume] in Urine by Automated count
68
727
0.92
0.22
5.9
3.1
e6/l
0.4
0.5
0.20
52
545
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
6.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
4.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
4.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
89
1.24
0.21
1.6
1.8
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
1.0
—
0
6
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
49
1.23
0.20
1.5
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
235
2306
1.07
0.18
40.7
13.6
ml/min/173m2
70.0
79.5
4.88
216
1870
(4010399)
20
176
1.15
0.18
1.3
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
21
236
0.88
0.17
2.4
2.1
nmol/l
9.6
13.5
1.23
13
205
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
240
2440
0.94
0.17
6.9
4.9
mmol/l
2.2
2.7
12.71
226
2215
(3010813) Leukocytes [#/volume] in Blood
274
2705
1.08
0.17
79.3
20.8
e9/l
8.0
6.9
9.89
267
2622
(3027944) Amphetamines [Presence] in Urine
8
68
1.18
0.16
2.3
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
19
214
0.88
0.16
1.7
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
95
914
1.06
0.14
7.0
3.8
e6/l
57.2
173.6
0.91
81
671
(3007461) Platelets [#/volume] in Blood
273
2702
1.06
0.12
80.0
20.8
e9/l
266.3
241.5
4.20
266
2632
(3022145) Colonoscopy Study observation
28
259
1.09
0.12
1.6
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
273
2705
1.06
0.11
79.5
20.8
e12/l
4.1
4.5
20.98
266
2624
(3024731) MCV [Entitic volume]
273
2705
1.06
0.11
79.3
20.7
fl
91.0
91.3
0.52
267
2661
(3035941) MCH [Entitic mass]
273
2705
1.06
0.11
79.1
20.7
pg
29.8
30.5
7.41
267
2661
(3000963) Hemoglobin [Mass/volume] in Blood
273
2706
1.05
0.10
80.2
20.9
g/l
121.0
136.9
34.51
267
2662
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
235
2376
0.96
0.09
6.9
4.4
mmol/l
4.0
4.5
10.40
222
2178
(3045414) Leukocytes [Presence] in Urine
10
88
1.14
0.08
1.3
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
65
1.08
0.08
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
67
1.05
0.08
1.7
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
68
1.03
0.08
1.7
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
234
2360
0.97
0.06
6.9
4.3
mmol/l
1.2
1.4
7.50
223
2138
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
231
2291
1.03
0.06
6.4
3.9
mmol/l
1.6
1.3
4.06
221
2065
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
44
426
1.04
0.05
4.7
3.0
e6/l
3.8
1.5
1.11
35
235
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
12
112
1.07
0.03
1.1
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
255
2542
1.01
0.01
59.6
13.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
14
134
1.05
0.00
4.6
3.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
123
0.97
0.00
1.1
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
7.9
—
0
8
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
5.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
0.3
—
0
5
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
35.8
—
0
5
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
69
1.01
0.00
1.7
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44813793)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_ACQUI_ABSENCE_LIMB – Acquired absence of limb
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).